Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx

[PR Newswire] – CARLSBAD, Calif., Feb. 14, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS) announced today that the Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending ISIS-TTRRx for designation as an orphan more

View todays social media effects on ISIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Isis is hiring next, click here to view